Clinical Trial Update: Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant [NA]

View source ↗

Summary

A clinical trial registry entry describes a study evaluating serum- and OCT biomarkers in patients with diabetic macular edema treated with anti-VEGF therapy or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Dexamethasone implant (Ozurdex) (dexamethasone implant)
• anti-VEGF therapy

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Diabetic Macular Edema, Visual Impairment | NA | Status: RECRUITING